Normal cerebral cortical thickness in first-degree relatives of temporal lobe epilepsy patients.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
22 01 2019
Historique:
received: 06 02 2018
accepted: 20 09 2018
pubmed: 28 12 2018
medline: 18 10 2019
entrez: 28 12 2018
Statut: ppublish

Résumé

To examine cerebral cortex thickness in asymptomatic first-degree relatives of patients with mesial temporal lobe epilepsy (MTLE). We investigated 127 asymptomatic first-degree relatives of patients with MTLE due to hippocampal sclerosis (HS) (mean age ± SD = 39.4 ± 13 years) and 203 healthy control individuals (mean age ± SD = 36.0 ± 11 years). Participants underwent a comprehensive clinical evaluation and structural brain MRI at 3 study sites. Images were processed simultaneously at each site using a surface-based morphometry method to quantify global brain measures, hippocampal volumes, and cerebral cortical thickness. Differences in brain measures between relatives of patients and controls were examined using generalized models, while controlling for relevant covariates, including age and sex. None of the asymptomatic first-degree relatives of MTLE + HS patients showed evidence of HS on qualitative image assessments. Compared to the healthy controls, the asymptomatic relatives of patients displayed no significant differences in intracranial volume, average hemispheric surface area, or hippocampal volume. Similarly, no significant cerebral cortical thinning was identified in the relatives of patients. This was consistent across the 3 cohorts. Lack of cortical thickness changes in the asymptomatic relatives of patients indicates that the previously characterized MTLE + HS-related cortical thinning is not heritable, and is likely driven by disease-related factors. This finding therefore argues for early and aggressive intervention in patients with medically intractable epilepsy.

Identifiants

pubmed: 30587513
pii: WNL.0000000000006834
doi: 10.1212/WNL.0000000000006834
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e351-e358

Informations de copyright

© 2018 American Academy of Neurology.

Auteurs

Saud Alhusaini (S)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia. saud.alhusaini@gmail.com.

Magdalena A Kowalczyk (MA)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Clarissa L Yasuda (CL)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Mira K Semmelroch (MK)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Marilise Katsurayama (M)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Matheus Zabin (M)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Tamires Zanão (T)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Mateus H Nogueira (MH)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Marina K M Alvim (MKM)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Victória R Ferraz (VR)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Meng-Han Tsai (MH)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Mary Fitzsimons (M)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Iscia Lopes-Cendes (I)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Colin P Doherty (CP)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Gianpiero L Cavalleri (GL)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Fernando Cendes (F)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Graeme D Jackson (GD)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Norman Delanty (N)

From the Department of Molecular and Cellular Therapeutics (S.A., G.L.C., N.D.) and FutureNeuro Research Centre (G.L.C., N.D.), the Royal College of Surgeons in Ireland, Dublin; Department of Neurology and Neurosurgery (S.A.), Montreal Neurological Institute and Hospital, Canada; The Florey Institute of Neuroscience and Mental Health (M.A.K., M.K.S., G.D.J.), Austin Campus, Melbourne, Australia; Neuroimaging Laboratory, Department of Neurology (C.L.Y., M.K., M.Z., T.Z., M.H.N., M.K.M.A., V.R.F., I.L.-C., F.C.), University of Campinas, São Paulo, Brazil; Department of Neurology (M.-H.T.), Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Brain Morphometry Laboratory (M.F.) and Division of Neurology (N.D.), Beaumont Hospital; Department of Neurology (C.P.D.), St James's Hospital, Dublin, Ireland; and Department of Neurology (G.D.J.), Austin Health, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH